ICON plc (ICLR)
181.26
-0.84
(-0.46%)
USD |
NASDAQ |
Dec 09, 16:00
181.26
0.00 (0.00%)
After-Hours: 18:50
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 13.84B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -16.26% |
| Valuation | |
| PE Ratio | 24.50 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 1.794 |
| Price to Book Value | 1.483 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.3826 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 63.43% |
Profile
| ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the development, management and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S. and Other. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland. |
| URL | http://www.iconplc.com |
| Investor Relations URL | https://investor.iconplc.com/ |
| HQ State/Province | Dublin |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Next Earnings Release | Feb. 25, 2026 (est.) |
| Last Earnings Release | Oct. 22, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the development, management and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S. and Other. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland. |
| URL | http://www.iconplc.com |
| Investor Relations URL | https://investor.iconplc.com/ |
| HQ State/Province | Dublin |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Next Earnings Release | Feb. 25, 2026 (est.) |
| Last Earnings Release | Oct. 22, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |